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Introduction
Down syndrome (DS) is one of the most common birth
defects in the United States1 and is characterized by a
heterogenous phenotype that results from a dosage
imbalance of genes on human chromosome 21.2 This
results in an increased incidence of infections, malignancy, autoinflammatory, and autoimmune conditions.3
Due to the heterogenous phenotype and complex needs
of the child with DS, the American Academy of Pediatrics
put out a clinical report for the health supervision of children with DS.4 This report gives information and guidance on when to screen for specific conditions and when
to refer to specialty care for evaluation. Inflammatory
arthritis in children with DS was first described in 19845
and is termed Down syndrome-associated arthritis (DA).
Studies have shown that DA is under-recognized with a
19-month average delay in diagnosis,6 and most patients
present with polyarticular (5 or more joints with arthritis), rheumatoid factor (RF), and anti-nuclear antibody
(ANA) negative disease.6 There are reports that DA is
more prevalent than juvenile idiopathic arthritis (JIA),7,8
which is the most common pediatric rheumatologic
disease.9 Despite this the American Academy of
Pediatrics does not mention arthritis or screening for
arthritis in the clinical report for health supervision of
children with DS. In a survey of pediatric rheumatologists asked how they evaluate for DA, it was found that
most use a combination of clinical history, physical
exam, laboratory tests, and imaging studies,10 however,
there is currently no standardized approach for the
assessment of DA. Additionally, it is unclear how primary care providers assess for DA prior to presentation
to subspecialty care. Our objective was to describe the
current practices of Down syndrome clinic providers
approach to assessment and diagnosis of DA.

Methods and Materials
Using the REDCap platform, an electronic survey was
created which consisted of 12 questions organized into

sections regarding responder demographic characteristics, assessment, and evaluation of inflammatory arthritis in Down syndrome. Survey questions used branching
logic and asked if providers were aware of DA, how
they screened for it, how they diagnosed it, and if they
educated families about the risk of DA. The survey
questions gave multiple choices and, “choose all that
apply” questions with a list of laboratory tests, and
imaging studies. Many questions had an “other” category for the respondent to fill-in responses that may not
be listed.
The survey was electronically sent to the Down
Syndrome Medical Interest Group-USA (DSMIG-USA)
electronic list-serv. The DSMIG-USA is a group of
health professionals committed to promoting optimal
health care and wellness of individuals with Down syndrome across the life span. Members of DSMIG-USA
are professionals from a variety of disciplines who provide care to individuals with Down syndrome and their
families. Members include physicians, scientists, psychologists, nurses, genetic counselors, educators, therapists, clinic coordinators, and related health professionals.
Most members work in specialized Down syndrome
clinics. Those on the DSMIG-USA electronic list-serv
were invited by e-mail to complete the survey. Participants
were asked to respond according to their personal experience, not that of institution, group practices, or based on
medical literature. Respondents were asked to quantify
their experience by years of practice. The survey was
sent on 3 separate occasions over a 4-month period
of time.
The results were analyzed by descriptive statistics
performed using IBM SPSS Statistics version 24.
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Table 1. Survey Respondent Characteristics of Down
Syndrome Clinic Providers.
Characteristics
Practice scope
Pediatric
Family medicine
Internal medicine
Genetics
Developmental pediatrics
Other subspecialty
Clinic location
Urban
Rural
Clinic setting
Academic
Private practice
Experience (by years of practice)
0-5 years
5-9 years
10+ years
Clinical time
0-25%
26-50%
51-75%
>75%

n (%)
15 (39)
5 (13)
2 (5)
5 (13)
3 (8)
6 (15)
38 (97)
1 (3)
25 (64)
14 (36)
8 (20)
5 (13)
26 (67)
8 (21)
6 (15)
6 (15)
19 (49)

Ethical Approval and Informed
Consent
This work was conducted in accordance with the
Declaration of Helsinki. Institutional review board
approval was obtained from Children’s Mercy Kansas
City (Study00000609). All respondents consented when
they voluntarily completed the survey.

Results
Of 46 survey responses received, 39 were included in
analyzed as 7 were duplicate responses. Most respondents were physicians (77%) followed by nurse practitioners (13%), and trainees (10%). Most are practicing
in pediatrics (39%), followed by family medicine (13%),
and genetics (13%). Respondents also reported a scope
of practice that included other subspecialty care (15%),
internal medicine (5%), and developmental pediatrics
(5%). Over half (67%) had 10+ years of practice experience in their respective field managing patients with
Down syndrome. Nearly half of the respondents (49%)
had greater than 75% time committed to clinical duties,
and most practiced in an urban location (97%) an in an
academic setting (64%) (Table 1).

The majority are aware of the risk for arthritis in DS
(77%), and most screen for DA (74%) using history
(82%) and physical exam (72%) to assess for arthritis.
Few use laboratory tests (3%) or imaging (3%) studies
as part of the diagnostic evaluation for arthritis. If laboratory tests are obtained, most obtain an anti-nuclear
antibody (ANA; 56%), c-reactive protein (CRP; 67%),
erythrocyte sedimentation rate (ESR; 64%), and complete blood count (CBC; 54%). If imaging is obtained,
the most common study is a computed tomography scan
(CT; 56%). Of survey responses, about half (49%) educate families about the risk for those with DS to develop
arthritis (Figure 1).

Discussion
Down syndrome-associated arthritis (DA) remains a
significant source of morbidity for children with Down
syndrome (DS). Previous studies have shown that DA is
under-recognized with delays in diagnosis, and frequently presents with extensive joint involvement.6 This
survey describes the real-world approach to assessment
and diagnosis of DA by surveyed DSMIG-USA
members.
Many of the DSMIG-USA members are aware of the
risk for arthritis in children with DS, however, assessment and screening are more complex due to lack of
guidance. In the most recent version of the American
Academy of Pediatrics Health Supervision of Children
with Down Syndrome,4 which is used by physicians and
healthcare providers to help guide screening in patients
with DS, there is no mention of surveillance for arthritis.
This makes it challenging to offer guidance or regular
screening to families and patients. This likely explains
why most the DSMIG-USA providers are aware of DA,
and nearly half provide education to families about DA.
A standardized, routine assessment to screen for DA or
inclusion and guidance by the American Academy of
Pediatrics Health Supervision of Children with Down
Syndrome4 could be used by primary care physicians
and healthcare providers to assess for DA to improve
areas of screening and education.
As there are no criteria for diagnosis of DA we found
that many DSMIG-USA clinicians surveyed used a combination of history and physical exam to guide evaluation. Few ordered laboratory tests or imaging studies
as part of their evaluation, but those that did, obtained
commonly used tests to evaluate for inflammation and
inflammatory changes (CBC, CRP, ESR). Additionally,
an ANA and RF were frequently obtained as part of
screening, which is commonly obtained when auto
immune or rheumatic diseases are considered on the differential. However, this approach may be problematic as
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Figure 1. Laboratory tests and imaging modalities and the percentage of Down syndrome clinic providers that use these
studies to screen for Down syndrome-associated arthritis.

studies show that most patients with DA present with
normal CRP, ESR,6,8 RF, and negative ANA.6,8 Therefore,
laboratory screening modalities and results must be interpreted cautiously as this alone may be a poor screening
and diagnostic evaluation tool for DA. Imaging modalities were not frequently used, but most would consider
obtaining CT for evaluation. While this option can obtain
critical information about joints and bones it also comes
with radiation exposure, which should be limited in those
that are already at increased risk for malignancy.11 For
pediatric rheumatologists, X-rays were the most used
imaging modality used to aid in evaluation of DA,10 and
is likely due to their accessibility, reproducibility and
relatively inexpensive. However, X-rays are not sensitive
enough to reveal subtle or early arthritis, and if changes
are seen on X-ray it would likely indicate more chronic
damage from arthritis. Ultrasound was the second most
used imaging modality by pediatric rheumatologists,10
and could be part of a novel approach to screening and
diagnosis of DA since there is no need for sedation and
no radiation exposure. Ultrasound also has the capabilities to pick up more subtle disease and tendon changes,
but it does have limitations, which includes that it is

operator dependent and may not be as reproducible from
1 technician to another making it difficult to assess and
follow disease.12
Our study has several limitations including the low
number of respondents, however, this was focused on
providers in DS clinics who predominantly see children
with DS. Participation bias was another limitation to our
study as it is possible that many chose not to complete
the survey due to lack of experience with DA. Another
limitation is that respondents may have answered the
survey questions based on information other than their
personal experience due to the hypothetical nature of the
questions and lack of details that would be seen in a
case-based survey. However, the focus of this survey
was intended to describe the current assessment and
approach to develop a baseline for providers.
This is the first study to evaluate Down syndrome
clinic providers perspectives towards diagnostic
approach and assessment of DA. Most Down syndrome
clinic providers are aware of DA, and almost half educate families about the risk for DA. Most utilizing history and physical exam, but rarely use laboratory tests or
imaging modalities to assess for DA. More research is
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needed to determine optimal education for families,
diagnostic approach, and assessment specific to DA.
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